Data identified that in the low HER2 cohort and different ATM levels (high/low); ABL1, SMAD4, RB1 and PARP1 were significantly upregulated and AKT1, AKT2, TSC2, RPTOR and mTOR were significantly downregulated in bladder cancer (Table S4). This evidence concerns the gene TSC2 and urinary bladder carcinoma.